Biocept entered into a supply agreement with Aegea Biotechnologies for a new PCR-based Covid-19 assay kit. Shares of Biocept fell 1.
Is there room left right now to talk about healthcare companies not connected in any way to a COVID-19 test, vaccine or treatment? …
It has been three weeks since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both the …
It’s a very rewarding trading day for investors in Biocept (BIOC) with shares up nearly 80%, making the stock Wall Street’s bull of …
It’s a very rewarding trading day for investors in Biocept (NASDAQ:BIOC) with shares up over 50%, making the stock Wall Street’s bull of …
Biocept Inc (NASDAQ:BIOC) shares are tumbling nearly 24% in Friday’s trading session. The reason?
Shares of Biocept Inc (NASDAQ:BIOC) slumped on Wednesday, falling 34% as of 12:48PM EST, following the announcement of a dilutive equity offering. The …
So what to make of Biocept Inc’s (NASDAQ:BIOC) latest success? On Tuesday, the tiny-size drug maker stunned Wall Street with the issuance of …
In the biotech-verse, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biocept Inc (NASDAQ:BIOC) are in opposite standing. According to one of the best analysts …
Biocept Inc (NASDAQ:BIOC) investors celebrate a 60% gain in the stock after the molecular diagnostics company announced that it has secured an in-network provider …
